glp-1 oral drugs GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Lilly widens GLP-1 lead—for now

If you have bipolar disorder, it might make mania more likely

10.7554/eLife.02523 31 Do VanB.GouelF.JonneauxA.TimmermanK.GelP.PtraultM.et al (2016)

This glutathione system acts as the major reduction-oxidation buffer in aerobic bacterial cells, contributing to the overall reduced cellular environment of the cytosol

Hydroxocobalamin: Adverse reactions (IV use)

Start with every other day for the first week to see how your skin responds, then gradually increase to daily use

With GLP-1 therapies like WEGOVY and ZEPBOUND showing dramatic weight-loss outcomes, many wonder if they could reduce or even replace the need for bariatric surgery